Hyperprolactinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 37: | Line 37: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Hyperprolactinemia history and symptoms|History and Symptoms]] | [[Hyperprolactinemia physical examination|Physical Examination]] | [[Hyperprolactinemia laboratory findings|Laboratory Findings]] | [[Hyperprolactinemia CT|CT]] | [[Hyperprolactinemia MRI|MRI]] | [[Hyperprolactinemia other imaging findings|Other Imaging Findings]] | [[Hyperprolactinemia other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | ==Treatment== | ||
Revision as of 15:26, 20 September 2012
For patient information click here
| Hyperprolactinemia | |
| ICD-10 | E22.1 |
|---|---|
| ICD-9 | 253.1 |
| DiseasesDB | 6314 |
| MeSH | D006966 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
|
Hyperprolactinemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperprolactinemia On the Web |
|
American Roentgen Ray Society Images of Hyperprolactinemia |
Synonyms and keywords: Hyperprolactinaemia; Ahumada-DelCastillo syndrome; Chiari-Frommel syndrome; Forbes-Albright syndrome
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hyperprolactinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.